Cytovation Alternatives & Competitors
12 companies similar to Cytovation — Creating transformative medicines for patients with cancer
Companies similar to Cytovation
ImmunoGenesis, Inc.
Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...
Houston, United States
Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Houston, United States
Epsilogen Ltd
Harnessing the power of IgE
United Kingdom
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
Rival Readout
Competing with Cytovation? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Taiga Biotechnologies
Taiga Biotechnologies is a clinical stage biotechnology company focused on harnessing the...
Aurora, United States
Aulos Bioscience
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immune...
Larkspur, United States
Outpace Bio
Revolutionizing Cell Therapy with Protein Design
Seattle, United States
Surface Oncology Inc.
#lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2...
Cambridge, United States
LAVA Therapeutics N.V.
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fi...
Utrecht, The Netherlands
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
About Cytovation
Cytovation ASA is a biotechnology startup based in Norway, with a vision to revolutionize cancer treatment. Its lead asset, CyPep-1, is a synthetic peptide designed to target tumor cells with a dual mechanism of action. This includes direct tumor-specific membrane lysis and in-situ vaccination, as well as immune activa...
Immuno-oncology, Biotech, Clinical Stage, Immunotherapy, Synthetic Peptide, Tumor-specific, Solid Tumors, In-situ Vaccination, Immune Activation, β-catenin Pathway, Clinical Development, Cancer Treatment, Oncology, Pharmaceuticals
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cytovation: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cytovation on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
